Ilex Medical (ILX) — Tangible Net Worth Ratio
Ilex Medical (ILX) has a Tangible Net Worth Ratio of 97.9% as of June 2025. This metric is calculated by deducting intangible assets (ILA13.57 Million) from net assets (ILA660.36 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Ilex Medical to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Ilex Medical Tangible Net Worth Ratio (2008–2024)
This chart shows how Ilex Medical's Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 97.9%, reflecting net assets of ILA660.36 Million with intangible assets of ILA13.57 Million ILA. See Ilex Medical (ILX) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Ilex Medical (2008–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Ilex Medical from 2008 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ILX stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.4% | ILA646.49 Million | ILA17.08 Million | ILA994.07 Million | ▲ +0.8 pp |
| 2023 | 96.6% | ILA623.51 Million | ILA21.27 Million | ILA1.02 Billion | ▲ +0.7 pp |
| 2022 | 95.9% | ILA613.10 Million | ILA25.10 Million | ILA899.18 Million | ▲ +0.4 pp |
| 2021 | 95.5% | ILA575.57 Million | ILA25.95 Million | ILA875.07 Million | ▲ +2.7 pp |
| 2020 | 92.8% | ILA443.54 Million | ILA31.77 Million | ILA779.25 Million | ▲ +4.3 pp |
| 2019 | 88.6% | ILA323.48 Million | ILA36.96 Million | ILA581.85 Million | ▲ +3.1 pp |
| 2018 | 85.5% | ILA293.49 Million | ILA42.60 Million | ILA533.38 Million | ▲ +4.0 pp |
| 2017 | 81.4% | ILA266.15 Million | ILA49.37 Million | ILA484.92 Million | ▲ +4.1 pp |
| 2016 | 77.4% | ILA244.51 Million | ILA55.29 Million | ILA487.56 Million | ▲ +5.4 pp |
| 2015 | 72.0% | ILA225.99 Million | ILA63.33 Million | ILA481.60 Million | ▲ +15.0 pp |
| 2014 | 57.0% | ILA204.60 Million | ILA87.95 Million | ILA506.54 Million | ▲ +4.6 pp |
| 2013 | 52.4% | ILA214.38 Million | ILA101.95 Million | ILA534.54 Million | ▲ +9.4 pp |
| 2012 | 43.0% | ILA259.96 Million | ILA148.12 Million | ILA600.69 Million | ▲ +15.4 pp |
| 2011 | 27.6% | ILA282.99 Million | ILA204.95 Million | ILA687.23 Million | ▼ -72.0 pp |
| 2010 | 99.5% | ILA120.80 Million | ILA571.00K | ILA191.62 Million | ▼ -0.3 pp |
| 2009 | 99.8% | ILA127.32 Million | ILA253.00K | ILA192.91 Million | ▲ +0.1 pp |
| 2008 | 99.7% | ILA109.44 Million | ILA277.00K | ILA170.14 Million | — |